Abstract We investigated the distribution of CARTp in rat lower urinary tract and evaluated its effect on urinary bladder function in vitro. Immunohistochemistry and a vertical isolated tissue bath system were used. Neurons, clusters of nonneuronal endocrine cells, and nerve fibers stained positive for CARTp in young adult rat urinary bladder. The CARTp-expressing neuronal elements were nitric oxide synthase (NOS)-and tyrosine hydroxylase (TH)-IR, whereas all nonneuronal CARTp-IR elements stained positively only for TH (100 %). In isolated bladder strips, CARTp significantly increased the amplitude of electric field stimulation (EFS)-induced detrusor contractions at stimulation frequencies ≤12.5 Hz (p≤0.001) as well as amplitude and frequency of spontaneous phasic urinary bladder smooth muscle (UBSM) contractions (p≤0.05). The responses to CARTp stimulation were dose-dependent and increased in the presence of the urothelium. To determine if the CARTp increase in nervemediated contractions may involve an action of CARTp on specific neural pathways, we blocked cholinergic, purinergic, and adrenergic pathways and determined CARTp actions on EFS-medicated contractions. CARTp enhancement of EFSmediated contractions does not involve alteration in purinergic, adrenergic, or cholinergic pathways. The study demonstrates that CARTp is highly expressed in rat urinary bladder. CARTp increased the amplitude of EFSinduced detrusor contractions as well as the amplitude and frequency of spontaneous phasic urinary bladder smooth muscle contractions. We conclude that CARTp may alter the release of compounds from the urothelium that leads to an enhancement of UBSM contractility/excitability.
Introduction
Results from previous studies implicate possible participation of cocaine-and amphetamine-regulated transcript peptides (CARTp) in multiple physiological processes Koylu et al. 1998; Adams et al. 1999; Kuhar and Dall Vechia 1999; Wierup et al. 2006) . A network of CARTpimmunoreactive (IR) neurons along the sympathoadrenal axis is implicated in sympathetic nerve-regulated activities (Dun et al. 2000a (Dun et al. , b, 2006 Matsumura et al. 2001; Wang et al. 2006) . Intracerebroventricular injections of CART and CART peptides increased sympathetic nervous system activity suggesting central roles for CARTp in modulating sympathetic activity. CARTp peptides may also play roles in the peripheral nervous system to influence target organ function Dun et al. 2000a) and to be neuroprotective following spinal cord injury (Bharne et al. 2013) .
Neural pathways that regulate micturition are complex, involving sympathetic, parasympathetic, and somatic systems. Sympathetic activation inhibits reflex parasympathetic outflow and unwanted bladder emptying promoting bladder filling and urinary continence Koylu et al. 1997; Gosling et al. 1999; Dun et al. 2000b; Andersson and Arner 2004; Fowler et al. 2008) . Several lower urinary tract diseases/conditions are associated with a decrease in bladder capacity, increased frequency of voiding, urge and urinary incontinence, all of which significantly affect quality of life (Steers 2002; Coyne et al. 2008) . Traditional anticholinergic therapies are limited in their effectiveness; therefore, new pharmacologic therapies/targets to treat such voiding disorders are needed (Herbison et al. 2003) . In our previous work, we have reported a dense network of CARTp -IR fibers and cells in the developing and adult rat urinary bladder (Zvarova and Vizzard 2005) . Autonomic intramural neurons and neuroendocrine catecholamine secreting cells known as paraganglia (extrachromaffin cells) in the adult rat expressed CARTp-IR (Dun et al. 2000a; Zvarova and Vizzard 2005; Girard et al. 2006; Wang et al. 2006) . The contribution of CARTp in rat lower urinary tract function is not known; therefore, we have carried out an initial series of experiments to (1) determine the distribution of CARTp in the young adult rat urinary bladder using immunohistochemistry, (2) elucidate the chemical coding patterns of subpopulations of CARTp-IR cells using multiple label immunohistochemistry, and (3) determine functional properties of CARTp and its effects on nerve-mediated and spontaneous urinary bladder smooth muscle (UBSM) contractility in vitro.
Materials and Methods
Young adult female Wistar rats (6-8 weeks of age; Charles River, Canada; 150-200 g) were used in these studies. The University of Vermont Institutional Animal Care and Use Committee (IACUC) approved all experimental protocols and procedures involving animals. Efforts were made to minimize the potential for animal pain, stress, or distress.
Tissue Harvesting
Animals were euthanized by isoflurane (3-4 %) anesthesia followed by exsanguination. Urinary bladders were dissected and placed in room temperature oxygenated (95 % O 2 and 5 % CO 2 ) physiological saline solution (PSS) (119.0 mM NaCl, 4.7 mM KCL, 24.0 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 .7H 2 O, 11.0 mM glucose, 2.5 mM CaCl 2 , pH 7.4).
Whole Mount Bladder Preparation for Immunohistochemical Studies
The bladder was cut open through the urethra in the midline along the ventral bladder wall and pinned flat on a Sylgardcoated dish. Immediately after maximal stretch of the tissue, the bladder was fixed for 1.5 h in cold fixative (2 % paraformaldehyde+0.2 % picric acid). The urothelium was then removed by dissection from the detrusor with fine microforceps and iris scissors. Each layer was processed separately by using a free-floating method. The preparations were placed in 0.1 M sodium phosphate buffered saline (0.1 M PBS) containing 1 % goat serum and Triton-X 100 for 30 min to increase tissue permeability and minimize nonspecific binding of antibodies. Tissues were incubated overnight at room temperature with primary antiserum rabbit anti-CARTp (rat 55-102, Phoenix Pharmaceuticals, Belmont, CA; 1:16,000). To determine the chemical coding of CARTp-IR cell subpopulations in rat urinary bladder, we have used several antibodies and performed double-labeling immunohistochemistry for cell-type determination. Mouse anti-neuronal nitric oxide synthase (nNOS or NOS1) was used as a marker for nitrergic neurons (Santa Cruz Biotechnology, Inc., Santa Cruz, CA; 1:100); mouse anti-tyrosine hydroxylase (TH) was used as a marker for catecholaminergic cells (Chemicon International, Inc. Temecula, CA; 1:100). After removal from the primary antiserum, the tissues were washed (3×15 min) with 0.1 M PBS (pH 7.4) and incubated with Cy3-conjugated goat antirabbit IgG (1:500; Jackson ImmunoResearch, West Grove, PA) or goat anti-mouse fluorescein isothiocyanate (FITC; Jackson ImmunoResearch) for 2 h at room temperature. After three final rinses (3×15 min) in 0.1 M PBS, tissues were mounted on 0.5 % gelled slides and cover slipped using Citifluor (Citifluor, London, UK).
Assessment of Immunohistochemical Staining in Urinary Bladder
Tissues were examined under an Olympus fluorescence photomicroscope for visualization of Cy3 or FITC. Cy3 was visualized using a filter with an excitation range of 560-596 nm and emission range from 610 to 655 nm, while FITC was visualized using a filter with an excitation range of 470 nm and emission range at 525 nm. Cell profiles were counted in whole-mount preparation of bladder musculature from 27 animals for CARTp-IR, 9 animals for NOS-IR, and 6 animals for TH-IR. Individual cells could be identified and only cell profiles with a nucleus were quantified. Numbers of CARTp-, nNOS-, and TH-IR cells per bladder are presented as mean±standard error (SEM). Because labeled cell bodies were not counted in tissue sections, correction factors for possible double counting of individual cells were not applied. To determine the total number of intramural neurons in the bladder specimens, we have used an antiserum directed against the pan neuronal marker Hu (n=6; anti-HuC/HuD; 1:200; Molecular Probes, Inc. Eugene, OR) combined with secondary antiserum (goat anti-mouse FITC; 1:50; Jackson ImmunoResearch). The neural origin of CARTp-IR fibers in both mucosa and detrusor smooth muscle was confirmed by staining with protein gene product (PGP) 9.5 (Biogenesis, Poole, England; 1:1,000), followed with Cy3-conjugated species-specific secondary antibodies. Digital images were obtained using a CCD camera (MagnaFire SP; Optronics; Optical Analysis Corp., Nashua, NH) and LG-3 frame grabber attached to an Olympus microscope (Optical Analysis Corp).
Images were imported in Adobe Photoshop 7.0 (Adobe Systems Incorporated, San Jose, CA) where figure sets were assembled and labeled.
Methodological and Specificity Controls and Assessment of Immunohistochemical Staining in Tissues
Immunohistochemistry in wholemount preparations of urinary bladder was performed on tissues simultaneously to reduce the incidence of staining variation that can occur between tissues processed on different day (Zvarova and Vizzard 2005) . Staining observed in experimental tissue was compared with that observed from experiment-matched negative controls. Urinary bladder wholemounts exhibiting immunoreactivity that was greater than the background level observed in experiment-matched negative controls were considered positively stained. Control tissues incubated in the absence of primary or secondary antibody were also processed and evaluated for specificity or background staining levels. In the absence of primary antibody, no positive immunostaining was observed (Zvarova and Vizzard 2005) .
In Vitro Contractility Studies
Freshly harvested bladder placed in cold oxygenated PSS was cut open through the urethra along the midline exposing the urothelial surface. Small strips (2-to 3-mm wide and 5-to 7-mm long), with (urothelium intact) and without urothelium (urothelium denuded), were cut from the bladder body. Thread loops were applied to the ends of each strip using surgical silk (4.0 U.S.P, LOOK, PA). Strips were mounted individually into the chambers (7-ml volume) of a vertical bath system (Catamount Research & Development Inc., St Albans, VT) filled with oxygenated PSS (95 % O 2 and 5 % CO 2 , 37°C). The experiment was initiated by establishing pretension of the bladder strips to 1 g and a 45-min equilibration period with bath solution exchanges every 15 min. Tissue viability was tested by three consecutive 5-min long applications of 60 mM KCl. Thirty minutes after the last KCl application, electrical field stimulation (EFS) was elicited by a pair of electrodes mounted parallel to the muscle strip in the tissue bath. EFS pulse train 2 s in duration were delivered at 0.5, 2.0, 3. 5, 5.0, 7.5, 10, 12.5, 15, 20, 30, 40 , and 50 Hz. Individual pulse width was 0.2 ms. Pulse amplitude was 20 V, and polarity was reversed for alternating pulses. Pulse trains were applied every 3 min using a model PHM-152 V stimulator (Catamount Research & Development Inc.) . At the completion of the first frequency-response curve, bladder strips were washed three times with fresh PSS. After 20 min, CARTp 100 nM (Rat 55-102, American Peptide Company, Inc., Sunnyvale, CA) was added directly to the chamber. Tissues were allowed to incubate for 15 min and then a second frequency-response curve was generated using the same EFS parameters previously used. This was followed by another 20-min-long rest period with washes and addition of 1 μM CARTp followed by a third frequency-response curve. Tetrodotoxin (TTX; 0.5 μM) was applied at the end of each experiment confirming a neural origin of the induced responses. The second set of experiments was designed to relate CARTp biological functions to one of the signaling pathways mediating bladder contraction. Muscarinic (atropine 1 μM), adrenergic (guanethidine 1 μM), or purinergic (suramin 1 μM) inhibitors (all from SigmaAldrich, Inc., St. Louis, MO) were applied alone and then in the presence of CARTp (100 nM).
EFS-induced frequency response curves were constructed and parameters between pairs of curves compared. Data were recorded and amplified with a computerized data acquisition program (MyoMed, Catamount Research & Development Inc.) , analyzed by exporting these data to Excel and OriginPro 8.1. The magnitude of spontaneous contractions was defined as absolute tension (g). Responses to CARTp were measured as the percentage change to the average amplitude obtained during the basal (i.e., pretreatment) UBSM strip activity. Data were analyzed using MiniAnalysis software (Synaptosoft, Inc., Fort Lee, NJ). Values are presented as mean±SD.
Statistical Analyses
For statistical comparisons, we used p≤0.05 as a threshold for rejection of the null hypothesis. Frequency-response curves were compared between various groups with a two-way ANOVA or two-way repeated-measures ANOVA, where appropriate. The Student-Newman-Keuls test was used for all multiple comparisons among means. Statistical analyses were performed with Prism 4.0 (GraphPad Software, San Diego, CA; www.graphpad.com). For all comparisons, two-way ANOVA with Bonferroni posttest was performed.
Results

Distribution of CARTp-Immunoreactive Fibers in Rat Urothelium
CARTp-IR nerve fibers were consistently found in all urothelium specimens examined (Fig. 1a) . CARTp-IR nerve fibers were most abundant in the urethra and in the region of the ureteric orifice. Moderate CARTp staining density was seen in the area of bladder body (Fig. 1a) , whereas no CARTpimmunoreactivity was observed in the bladder dome. The staining pattern for CARTp was identical to that obtained with the pan-neuronal marker protein gene product (PGP) 9.5 (data not shown). No urothelial cells expressed CARTpimmunoreactivity in any specimen examined.
Distribution of CARTp-Immunoreactivity in Rat Detrusor
Numerous CARTp-IR nerve fibers were observed in the detrusor associated with nerve trunks in the bladder body as well as in the urethra and ureters. In addition to the dense network of CARTp-IR nerve fibers in the detrusor, morphologically and chemically distinct groups of CARTp-IR cell bodies were also observed in young adult rat bladder (Fig. 1b, c) . Based on size, shape, and chemical coding, three subpopulations of cell bodies expressing CARTp-IR were noted (Figs. 2, 3 , and 4) and consistent with populations observed in neonatal rat urinary bladder (Zvarova and Vizzard 2005) , including neuronal cell bodies within intramural autonomic ganglia (CARTp+/ HuC/HuD+; Fig. 1b) , clusters of numerous nonneuronal cells (CARTp+/HuC/HuD-; Figs. 1b, c and 2b), and individual neurons scattered throughout the bladder wall (CARTp+/HuC/ HuD+; Fig. 2a, c) .
Staining of the whole mount bladder preparation enabled rapid and reliable screening, topographical distribution, and chemical coding determination of CARTp-IR in the bladder wall as demonstrated (Figs. 1, 2, 3, and 4) . Of the total CARTp-IR population present in the urinary bladder, 29.1 % was neuronal (Hu-IR; Fig. 4a-c, f) , whereas the majority of CARTp-IR cell bodies were nonneuronal. Within the neuronal (Hu-IR) bladder cell population, 40.6 % of cells were CARTp-IR. In the bladder of the young adult rat, 18.9 % of all nNOS-IR (Figs. 3 and 4f) and 76.3 % of all TH-IR cells were CARTp-IR (Fig. 4d-f) . TH was expressed by neurons (autonomic intramural ganglia) or by nonneuronal (Hu-negative) small sized, intensively stained cell bodies organized in 
Effect of CARTp on Amplitude of Electrically Induced Contractions in Urinary Bladder Smooth Muscle Strips
Effects of CARTp on nerve-evoked contractions of urinary bladder smooth muscle (UBSM) were studied. To determine sensitivity of rat urinary bladder strips to the repetitive EFS episodes, control experiments were performed in a set of strips (n=8) in which three consecutive frequency response curves were obtained without adding pharmacological agents. The values served as a baseline to which the corresponding experimental data were compared. Changes in the contraction amplitude are expressed as a percentage of control (pre-drug).
Application of CARTp (100 nM) potentiated the amplitude of EFS-induced contractions in both urothelium intact and urothelium denuded urinary bladder muscle strips. Potentiation was more pronounced in urothelium intact UBSM strips and at low frequency stimulation (≤12.5 Hz; Fig. 5 ). The amplitude of contraction was dose-related over a concentration range of 100 nM to 1 μM with a maximal increase from the baseline response to ∼156.6 % at 100 nM and 237.8 % at 1 μM in urothelium preserved, and ∼146.5 % at 100 nM and ∼193.9 % at 1 μM in urothelium denuded strips. To determine if the CARTp-increase in nerve-mediated contractions may involve an action of CARTp on specific neural pathways, we blocked cholinergic, purinergic, and adrenergic pathways and determined CARTp actions on EFS-medicated contractions. In the presence of cholinergic-(atropine 1 μM; Fig. 6a, b) , purinergic-(suramin, 1 μM; Fig. 6c, d ), or adrenergic-(guanethidine, 1 μM; Fig. 6e , f) mediated inhibition of electrically induced UBSM contractions, CARTp (100 nM) increased (p≤0.05) the peak amplitude of UBSM contractions (Fig. 6) . CARTp effects in electrically induced UBSM contractions in the presence of neurotransmitter blockade were significant (p≤0.05) only at low frequencies of stimulation (<12.5 Hz) in UBSM strips with an intact (Fig. 6a, c, e) and denuded (Fig. 6b, d, f) urothelium.
Effect of CARTp on Spontaneous Phasic UBSM Contractions
CARTp also increased the amplitude of spontaneous phasic UBSM contractions (p ≤ 0.05; Fig. 7 ). Concentrationdependent potentiation was comparable to the results obtained in EFS-induced contractions. No significant effect of CARTp on frequency was observed. TTX application did not alter the phasic UBSM contractility or the effect of CARTp (data not shown) suggesting direct CARTp effects on UBSM.
Discussion
The present study is a continuation of our initial study demonstrating CARTp -immunoreactivity in the urinary bladder wall of rat pups immediately following birth and during postnatal development (Zvarova and Vizzard 2005) . We now provide additional information of the distribution, morphology, and chemical coding of CARTp-IR in the urinary bladder wall, and the functional contribution of CARTp to urinary bladder excitability/contractility in young adult rats. This study demonstrates CARTp expression in the bladder mucosa and UBSM. CARTp expression was limited to the suburothelial plexus, neurons of intramural ganglia, paraganglia (nonneural), and nerve fibers throughout the urinary bladder smooth muscle (UBSM). With respect to CARTp distribution, the urethra, ureters, and bladder neck exhibited the greatest density of CARTp-IR nerve fibers with little CARTp-immunoreactivity in the bladder dome. The pattern of CARTp distribution in the young adult rat lower urinary tract was similar to that observed in early postnatal life (Zvarova and Vizzard 2005) . Chemical coding of CARTp-IR cells demonstrated that colocalization between CARTp and Fig. 5 Effect of CARTp on peak amplitude of EFS-evoked urinary bladder smooth muscle (UBSM) contractions in urothelium intact and urothelium denuded preparations isolated from young adult rat. EFSevoked UBSM contractions in the absence (control, a) and presence of CARTp (100 nM, b) in urothelium intact preparations. c Summary figure of effects of CARTp (100 nM) on peak amplitude of EFS-evoked UBSM contractions in urothelium intact preparations (* p≤0.05). EFS-evoked UBSM contractions in the absence (control, d) and presence of CARTp (100 nM, e) in urothelium denuded preparations. f Summary figure of effects of CARTp (100 nM) on peak amplitude of EFS-evoked UBSM contractions in urothelium denuded preparations (* p≤0.05). Sample size is n=8 nNOS or TH was frequent. CARTp increased the amplitude of EFS-induced detrusor contractions as well as the amplitude and frequency of spontaneous phasic UBSM contractions. In addition, we demonstrated that CARTp enhancement of EFSmediated contractions does not involve alteration in purinergic, adrenergic, or cholinergic pathways. CARTp can directly increase UBSM contractility and this action is greater in the presence of the urothelium. CARTp may alter the release of compounds from the urothelium that leads to an enhancement of UBSM contractility/excitability.
CARTp-immunoreactivity was demonstrated in distinct cell (i.e., neuronal and nonneuronal) populations in the urinary bladder. Intramural ganglia are present in the bladder wall and are heterogeneous in respect to neurotransmitter content (Dixon et al. 1983; Gabella 1990; Zhou and Ling 1998) , and the present studies confirm the expression of CARTp in these ganglia (Zvarova and Vizzard 2005) . The presence and arrangement of intramural ganglia allows for local regulation/ modulation of neuromuscular transmission and smooth muscle activity, intrinsic bladder activity, or reinforcing motor or sensory activity (Gabella 1990; Uvelius and Gabella 1998; Gillespie et al. 2006) . In addition to the distribution of CARTp-IR in neural structures, neuroendocrine cells/ paraganglia of the urinary bladder were also found to contain CARTp. These extra-adrenal, chromaffin, catecholamine-rich cells are an established feature of the bladder in many species including human (Hervonen et al. 1978; Partanen et al. 1984; Honma 1994 ). These cells contribute to local endocrine effects, regulation of bladder vascular and muscular tone, and demonstrate changes in number/distribution with pathology (Myles and Ducker 1973; Claustre et al. 1992; Honma 1994; Saito et al. 1997; Kershen et al. 2002) . CARTp increased the amplitude of EFS-induced detrusor contractions at lower stimulation frequencies (≤12.5 Hz). The responses to CARTp stimulation were dose-dependent and were increased in the presence of the urothelium. To determine if the CARTp-increase in nerve-mediated contraction involved an action of CARTp on specific neural pathways, we blocked cholinergic, purinergic, and adrenergic pathways and determined CARTp actions on EFS-mediated contractions. CARTp enhancement of EFS-mediated contractions did not involve alteration in purinergic, adrenergic, or cholinergic pathways. Follow-up studies using additional pharmacological tools as well as those that block specific receptor subtypes should be pursued to confirm that purinergic, adrenergic, or cholinergic pathways are not involved in CARTp enhancement of EFS-mediated contractions. However, CARTp increased the amplitude and frequency of spontaneous phasic UBSM contractions (TTX resistant), and this action was greater in the presence of urothelium. These effects on UBSM excitability/contractility may involve direct actions of CARTp on UBSM to increase contractility/excitability, changes in the release of compounds from the urothelium that increase UBSM contractility/excitability, or changes in neurotransmitter signaling. Future studies are necessary to determine if CARTp can induce ATP and/or NO release from urothelium (Fowler et al. 2008) .
The current immunohistochemical and contractility studies suggest that CARTp may function in neuroendocrine/intrinsic as well as in nerve-mediated bladder regulation. CARTp increased the amplitude of EFS-induced detrusor contractions as well as the amplitude and frequency of spontaneous phasic UBSM contractions. Urothelium removal decreased the magnitude of CARTp effects on bladder contractility, suggesting that these functions are mediated/potentiated, in part, by urothelial receptors and urothelial secretion of signaling molecules that may include ATP and/or NO. Although CARTp are highly expressed in rat urinary bladder, additional studies are needed to further define the role(s) of CARTp in the regulation of normal bladder function as well as in the regulation of bladder function in the presence of neural injury, disease, or inflammation. These future studies are hampered by the lack of understanding concerning CARTp receptors and strategies to effectively block CARTp/receptor signaling (Adams et al. 1999) .
